← All indications
Liver Diseases, Alcoholic
Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.
Subtype terms (3)
More specific conditions that are subtypes of Liver Diseases, Alcoholic in the MeSH hierarchy.
- Fatty Liver, Alcoholic
3 drugs (1 approved, 2 experimental)
- Hepatitis, Alcoholic
48 drugs (27 approved, 21 experimental)
- Liver Cirrhosis, Alcoholic
15 drugs (7 approved, 8 experimental)
Drugs by status
Phase 4 trials (6)
Phase 2 trials (3)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (15)
- Abbott
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- University of Sydney
- South West Sydney Local Health District
- University of California, Davis
- University of California, Los Angeles
- University of Colorado, Denver
- Macquarie University
- University of Lille
- Joint Clinical Research Centre, Kampala, Uganda
- Sydney Local Health District
- National Health and Medical Research Council, Australia
- ClinIntel
- Catalent
- Government of France
Organization Involved with Phase 2 Indications (4)
Organization Involved with Other Experimental Indications (6)